FDA — authorised 3 July 2008
- Application: NDA022090
- Marketing authorisation holder: BAYER HLTHCARE
- Local brand name: EOVIST
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 gadoxetic acid enhanced liver MRI in United States
FDA authorised gadoxetic acid enhanced liver MRI on 3 July 2008
Marketing authorisation
Other Diagnostic Imaging approved in United States
Frequently asked questions
Is gadoxetic acid enhanced liver MRI approved in United States?
Yes. FDA authorised it on 3 July 2008.
Who is the marketing authorisation holder for gadoxetic acid enhanced liver MRI in United States?
BAYER HLTHCARE holds the US marketing authorisation.